For: | Lorenzini S, Gitto S, Grandini E, Andreone P, Bernardi M. Stem cells for end stage liver disease: How far have we got? World J Gastroenterol 2008; 14(29): 4593-4599 [PMID: 18698672 DOI: 10.3748/wjg.14.4593] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i29/4593.htm |
Number | Citing Articles |
1 |
Toshitaka Hoppo, Junji Komori, Rohan Manohar, Donna Beer Stolz, Eric Lagasse. Rescue of Lethal Hepatic Failure by Hepatized Lymph Nodes in Mice. Gastroenterology 2011; 140(2): 656 doi: 10.1053/j.gastro.2010.11.006
|
2 |
|
3 |
Anna Chiara Piscaglia, Mariachiara Campanale, Antonio Gasbarrini, Giovanni Gasbarrini. Stem Cell-Based Therapies for Liver Diseases: State of the Art and New Perspectives. Stem Cells International 2010; 2010: 1 doi: 10.4061/2010/259461
|
4 |
Ziqi Guo, Shiming Pu, Yun Li, Xiaoxia Wang, Suying Hu, Hongxia Zhao, Cheng Yang, Zuping Zhou. Functional characterization of CD49f+ hepatic stem/progenitor cells in adult mice liver. Journal of Molecular Histology 2022; 53(2): 239 doi: 10.1007/s10735-022-10063-z
|
5 |
Caecilia H. C. Sukowati, Claudio Tiribelli. Cell Biology and Translational Medicine, Volume 17. Advances in Experimental Medicine and Biology 2022; 1401: 57 doi: 10.1007/5584_2022_719
|
6 |
Javier A. Cienfuegos, Jorge Baixauli. Células madre y regeneración hepática: mirando al futuro. Gastroenterología y Hepatología 2012; 35(9): 675 doi: 10.1016/j.gastrohep.2012.02.006
|
7 |
Owen G Davies, Paul R Cooper, Richard M Shelton, Anthony J Smith, Ben A Scheven. Isolation of adipose and bone marrow mesenchymal stem cells using CD29 and CD90 modifies their capacity for osteogenic and adipogenic differentiation. Journal of Tissue Engineering 2015; 6 doi: 10.1177/2041731415592356
|
8 |
István Kiss, Antal Tibold, Róbert Halmosi, Éva Bartha, Katalin Koltai, Zsuzsanna Orsós, László Bujdosó, István Ember. Enhancement of Organ Regeneration in Animal Models by a Stem Cell-Stimulating Plant Mixture. Journal of Medicinal Food 2010; 13(3): 599 doi: 10.1089/jmf.2009.0013
|
9 |
Qian Zhou, Lanjuan Li, Jun Li. Stem cells with decellularized liver scaffolds in liver regeneration and their potential clinical applications. Liver International 2015; 35(3): 687 doi: 10.1111/liv.12581
|
10 |
Elida Gripp Mannheimer, Luiz Fernando Quintanilha, Adriana Bastos Carvalho, Bruno Diaz Paredes, Felipe Gonçalves de Carvalho, Cristina Maeda Takyia, Célia Maria Coelho Resende, Guilherme Ferreira da Motta Rezende, Antonio Carlos Campos de Carvalho, Alberto Schanaider, Regina Coeli dos Santos Goldenberg. Bone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model. Clinical Transplantation 2011; 25(1): 54 doi: 10.1111/j.1399-0012.2009.01191.x
|
11 |
Cun-Gang Fan, Qing-jun Zhang, Jing-ru Zhou. Therapeutic Potentials of Mesenchymal Stem Cells Derived from Human Umbilical Cord. Stem Cell Reviews and Reports 2011; 7(1): 195 doi: 10.1007/s12015-010-9168-8
|
12 |
Magda M. El-Mahdi, Wafaa A. Mansour, Olfat Hammam, Noha A. Mehana, Taghreed M. Hussein. Ameliorative Effect of Bone Marrow-Derived Stem Cells on Injured Liver of Mice Infected with Schistosoma mansoni. The Korean Journal of Parasitology 2014; 52(2): 151 doi: 10.3347/kjp.2014.52.2.151
|
13 |
Kun Wang, Yuwen Li, Tiantian Zhu, Yongting Zhang, Wenting Li, Wenyu Lin, Jun Li, Chuanlong Zhu. Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure. Stem Cell Research & Therapy 2017; 8(1) doi: 10.1186/s13287-017-0614-2
|
14 |
Mahboobe Ghaedi, Abbas S. Lotfi, Masoud Soleimani. Establishment of lentiviral-vector-mediated model of human alpha-1 antitrypsin delivery into hepatocyte-like cells differentiated from mesenchymal stem cells. Tissue and Cell 2010; 42(3): 181 doi: 10.1016/j.tice.2010.03.007
|
15 |
Parvin Salehinejad, Noorjahan Banu Alitheen, Abdul Manaf Ali, Abdul Rahman Omar, Maryam Mohit, Ehsan Janzamin, Fazel Sahraneshin Samani, Zahra Torshizi, Seyed Noureddin Nematollahi-Mahani. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly. In Vitro Cellular & Developmental Biology - Animal 2012; 48(2): 75 doi: 10.1007/s11626-011-9480-x
|
16 |
Su Jong Yu, Jung-Hwan Yoon, Won Kim, Jeong Min Lee, Yun Bin Lee, Yuri Cho, Dong Hyeon Lee, Minjong Lee, Jeong-Ju Yoo, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Chung Yong Kim. Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis. The Korean Journal of Internal Medicine 2017; 32(2): 261 doi: 10.3904/kjim.2015.267
|
17 |
Atefeh Yaghoubi, Negar Azarpira, Saied Karbalay-Doust, Sajad Daneshi, Zahra Vojdani, Tahereh Talaei-Khozani. Prednisolone and mesenchymal stem cell preloading protect liver cell migration and mitigate extracellular matrix modification in transplanted decellularized rat liver. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02711-8
|
18 |
Ashish Kumar, Nirupama Trehan Pati, Shiv Kumar Sarin. Use of Stem Cells for Liver Diseases—Current Scenario. Journal of Clinical and Experimental Hepatology 2011; 1(1): 17 doi: 10.1016/S0973-6883(11)60114-X
|
19 |
Jun Li, Ran Tao, Wei Wu, Hongcui Cao, Jiaojiao Xin, Jing Guo, Longyan Jiang, Xutao Hong, Achilles A. Demetriou, Daniel Farkas, Lanjuan Li. Transcriptional profiling and hepatogenic potential of acute hepatic failure-derived bone marrow mesenchymal stem cells. Differentiation 2010; 80(2-3): 166 doi: 10.1016/j.diff.2010.04.002
|
20 |
Salam Idriss, Kazem Zibara, Bertrand Cariou, Karim Si-Tayeb. From Human-Induced Pluripotent Stem Cells to Liver Disease Modeling: A Focus on Dyslipidemia. Current Pathobiology Reports 2015; 3(1): 47 doi: 10.1007/s40139-015-0067-1
|
21 |
Tao Liu, Yingjie Wang, Guangping Tai, Shichang Zhang. Could co‐transplantation of iPS cells derived hepatocytes and MSCs cure end‐stage liver disease?. Cell Biology International 2009; 33(11): 1180 doi: 10.1016/j.cellbi.2009.08.007
|
22 |
Hanan El Baz, Zeinab Demerdash, Manal Kamel, Shimaa Atta, Faten Salah, Salwa Hassan, Olfat Hammam, Heba Khalil, Ali Bayoumi. Potentials of Differentiated Human Cord Blood-Derived Unrestricted Somatic Stem Cells in Treatment of Liver Cirrhosis. Experimental and Clinical Transplantation 2019; 17(2): 251 doi: 10.6002/ect.2017.0249
|
23 |
Fei Yi, Guang-Hui Liu, Juan Carlos Izpisua Belmonte. Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy. Protein & Cell 2012; 3(4): 246 doi: 10.1007/s13238-012-2918-4
|
24 |
Xiao-lun Huang, Le Luo, Lan-yun Luo, Hua Xue, Ling-ling Wei, Yu-tong Yao, Hai-bo Zou, Xiao-bing Huang, Yi-fan Zhu, Tian Zhang, Ping Xie, Mao-zhu Yang, Shao-ping Deng. Clinical Outcome of Autologous Hematopoietic Stem Cell Infusion via Hepatic Artery or Portal Vein in Patients with End-stage Liver Diseases. Chinese Medical Sciences Journal 2014; 29(1): 15 doi: 10.1016/S1001-9294(14)60018-3
|
25 |
Ning-Bo Hao, Chang-Zhu Li, Mu-Han Lü, Bo Tang, Su-Min Wang, Yu-Yun Wu, Guang-Ping Liang, Shi-Ming Yang. SDF-1/CXCR4 Axis Promotes MSCs to Repair Liver Injury Partially through Trans-Differentiation and Fusion with Hepatocytes. Stem Cells International 2015; 2015: 1 doi: 10.1155/2015/960387
|